Synopsis Autologous grafting is the gold standard for reconstruction of maxillofacial bone defects. Despite this, there are challenges faced by autologous grafting. The study aims at development and evaluation of a less invasive bone reconstruction technique using bone marrow-derived mesenchymal stromal cells (BM-MSCs) which would be devoid of the challenges faced by autologous bone grafting in a clinical setting.
This week's 'MED FACT' discusses a clinical trial from Stem Cell Research & Therapy, “ Cell therapy induced regeneration of severely atrophied mandibular bone in a clinical trial” . Authors : Cecilie Gjerde, Kamal Mustafa, Sølve Hellem et al. Key Takeaways Reconstruction of the alveolar ridge using autologous MSCs and…
